Department of Pulmonary Medicine, University of Freiburg, Germany.
Am J Respir Cell Mol Biol. 2011 Mar;44(3):423-9. doi: 10.1165/rcmb.2010-0038OC. Epub 2010 May 27.
Extracellular ATP is up-regulated in the airways of patients with chronic obstructive pulmonary disease, and may contribute to the pathogenesis of the disease. However, the precise mechanisms are poorly understood. Our objective was to investigate the functional role of the ATP receptor P2X(7) in the pathogenesis of cigarette smoke (CS)-induced lung inflammation and emphysema in vivo. Expression of the P2X(7) receptor (P2X(7)R) was measured in lung tissue und immune cells of mice with CS-induced lung inflammation. In a series of experiments using P2X(7) antagonists and genetically engineered mice, the functional role of the P2X(7)R in CS-induced lung inflammation was explored. CS-induced inflammation was associated with an up-regulation of the P2X(7)R on blood and airway neutrophils, alveolar macrophages, and in whole lung tissue. Selective intrapulmonary inhibition of the P2X(7)R reduced CS-induced lung inflammation and prevented the development of emphysema. Accordingly, P2X(7)R knockout mice showed a reduced pulmonary inflammation after acute CS exposure. Experiments with P2X(7)R chimera animals revealed that immune cell P2X(7)R expression plays an important role in CS-induced lung inflammation and emphysema. Extracellular ATP contributes to the development of CS-induced lung inflammation and emphysema via activation of the P2X(7)R. Inhibition of this receptor may be a new therapeutic target for the treatment of chronic obstructive pulmonary disease.
细胞外 ATP 在慢性阻塞性肺疾病患者的气道中上调,可能有助于疾病的发病机制。然而,其确切机制尚不清楚。我们的目的是研究 ATP 受体 P2X(7)在体内香烟烟雾 (CS) 诱导的肺炎症和肺气肿发病机制中的功能作用。在一系列使用 P2X(7)拮抗剂和基因工程小鼠的实验中,研究了 P2X(7)R 在 CS 诱导的肺炎症中的功能作用。CS 诱导的炎症与血液和气道中性粒细胞、肺泡巨噬细胞和整个肺组织中 P2X(7)R 的上调有关。选择性肺内抑制 P2X(7)R 可减少 CS 诱导的肺炎症并预防肺气肿的发展。因此,P2X(7)R 敲除小鼠在急性 CS 暴露后肺部炎症减轻。使用 P2X(7)R 嵌合体动物的实验表明,免疫细胞 P2X(7)R 表达在 CS 诱导的肺炎症和肺气肿中起重要作用。细胞外 ATP 通过激活 P2X(7)R 促进 CS 诱导的肺炎症和肺气肿的发展。抑制该受体可能是治疗慢性阻塞性肺疾病的新治疗靶点。